|
|
||||||||
The Journal of Immunology, Vol 143, Issue 3 844-850, Copyright © 1989 by American Association of Immunologists
ARTICLES |
HC Morse 3d, RA Yetter, CS Via, RR Hardy, A Cerny, K Hayakawa, AW Hugin, MW Miller, KL Holmes and GM Shearer
Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.
The functional and phenotypic characteristics of Ly-4(CD4)+ and Ly- 2(CD8)+ T cells were studied after induction of murine AIDS with LP-BM5 murine leukemia virus. Assays of spleen cells for their ability to generate in vitro CTL responses to TNP-modified autologous cells (self + x CTL) and to alloantigens (allo CTL) showed that self + x CTL responses were greatly impaired at 3 to 4 wk postinfection and were undetectable thereafter. Allo CTL responses were normal at 3 to 4 wk, but were reduced at 8 to 9 wk and absent at 14 wk postinfection. This sequential loss of self + x and allo CTL responses was related to a selective defect in Ly-4(CD4)+ Th cell function associated with impaired production of IL-2 and deficient proliferative responses to Con A or to soluble Ag. Changes in the functional characteristics of Ly- 4(CD4)+ T cells were unrelated to changes in their frequency in spleen, but did correlate with marked alterations in their distribution among four subsets defined by mAb SM3C11 and SM6C10. Assays of CTL responses generated by mixtures of spleen cells from normal and infected mice suggested that active suppression of Ly-4(CD4)+ Th function may contribute to this defect. Studies of Ly-2(CD8)+ T cells showed that infection with LP-BM5 murine leukemia virus also induced a major phenotypic shift in subpopulations defined by their reactivity with mAb 6C10. However, this phenotypic change did not appear to correlate with major functional defects.
This article has been cited by other articles:
![]() |
K. A. Green, T. Okazaki, T. Honjo, W. J. Cook, and W. R. Green The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome J. Virol., March 1, 2008; 82(5): 2456 - 2469. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Green, C. L. Ahonen, W. J. Cook, and W. R. Green CD40-Associated TRAF 6 Signaling Is Required for Disease Induction in a Retrovirus-Induced Murine Immunodeficiency J. Virol., June 1, 2004; 78(11): 6055 - 6060. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Green, W. J. Cook, A. H. Sharpe, and W. R. Green The CD154/CD40 Interaction Required for Retrovirus-Induced Murine Immunodeficiency Syndrome Is Not Mediated by Upregulation of the CD80/CD86 Costimulatory Molecules J. Virol., November 13, 2002; 76(24): 13106 - 13110. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. UMEMURA, H. NISHIMURA, T. YAJIMA, W. WAJJWALK, T. MATSUGUCHI, M. TAKAHASHI, Y. NISHIYAMA, M. MAKINO, Y. NAGAI, and Y. YOSHIKAI Overexpression of interleukin-15 prevents the development of murine retrovirus-induced acquired immunodeficiency syndrome FASEB J, November 1, 2002; 16(13): 1755 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Green, R. J. Noelle, B. G. Durell, and W. R. Green Characterization of the CD154-Positive and CD40-Positive Cellular Subsets Required for Pathogenesis in Retrovirus-Induced Murine Immunodeficiency J. Virol., April 15, 2001; 75(8): 3581 - 3589. [Abstract] [Full Text] |
||||
![]() |
I. A. Khan, W. R. Green, L. H. Kasper, K. A. Green, and J. D. Schwartzman Immune CD8+ T Cells Prevent Reactivation of Toxoplasma gondii Infection in the Immunocompromised Host Infect. Immun., November 1, 1999; 67(11): 5869 - 5876. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hugin, M. Vacchio, and H. Morse 3rd A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice Science, April 19, 1991; 252(5004): 424 - 427. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |